JACK MCAFEE: Open Payments
NPI 1659477032 · LA FOLLETTE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,683 in 113 payments from 35 companies in 2025. Trend: 2023 $2,369 · 2024 $2,631 · 2025 $2,683
Food & beverage: $2,384Education: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $255 |
| Novartis Pharmaceuticals Corporation | 9 | $183 |
| Incyte Corporation | 5 | $173 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| E.R. Squibb & Sons, L.L.C. | 12 | $163 |
| Gilead Sciences, Inc. | 3 | $151 |
| Exelixis Inc. | 3 | $142 |
| Merck Sharp & Dohme LLC | 6 | $131 |
| Lilly USA, LLC | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $119 |
Products named: Trodelvy, ERLEADA, REBLOZYL, KISQALI, VERZENIO, LIBTAYO, KEYTRUDA, OPDIVO.
Industry payments across TN — which companies pay providers there.
